Rinvoq ER 30 MG tablet UU 30S

Ended Awarded Last action

Contract number
SPE2DR26F0DCL
Awardee
Awarding agency
Obligated
$69,124

Award facts

Contract value 100% obligated
$69,124.37 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $69,124.37 delivery order to AmerisourceBergen Drug Corp on May 11, 2026, for RINVOQ ER 30 mg tablets (30-count packaging), with ultimate completion on May 12, 2026.

Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical devices to federal healthcare systems, primarily the Defense Logistics Agency through its DLA Troop Support Medical indefinite delivery contract.

Quick answers

Who was awarded contract SPE2DR26F0DCL?

SPE2DR26F0DCL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 11, 2026.

How much is contract SPE2DR26F0DCL worth?

The government has obligated $69,124 on SPE2DR26F0DCL.

Is contract SPE2DR26F0DCL an order under another contract?

Yes. SPE2DR26F0DCL is a delivery order under SPE2DR25D2206, an indefinite delivery contract.

Was contract SPE2DR26F0DCL competed?

The extent of competition for SPE2DR26F0DCL was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award